Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-11

Clinical Trial Update: Naltrexone vs Buprenorphine-Naloxone for Opioid Dependence in Norway [Phase 3]

View source ↗

Summary

Phase 3 trial comparing naltrexone to buprenorphine-naloxone for opioid dependence completed in Norway.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Buprenorphine/naloxone (buprenorphine/naloxone)
  • Naltrexone (Naltrexone)

Snippet

Sponsor: University of Oslo | Conditions: Opioid Dependence | Phase 3 | Status: COMPLETED